2022
An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma
Madoff DC, Abi-Jaoudeh N, Braxton D, Goyal L, Jain D, Odisio BC, Salem R, Schattner M, Sheth R, Li D. An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma. The Oncologist 2022, 27: 884-891. PMID: 35925597, PMCID: PMC9526481, DOI: 10.1093/oncolo/oyac139.Peer-Reviewed Original ResearchConceptsIntrahepatic cholangiocarcinomaBiomarker testingMultidisciplinary teamImage-guided liver biopsyMetastatic intrahepatic cholangiocarcinomaEvidence-based guidelinesIntrahepatic biliary treeNext-generation sequencingActionable genetic alterationsTreatment landscapeLiver biopsyMedical oncologistsInterventional oncologistsPoor prognosisAggressive malignancyBiliary treeTissue acquisitionBiopsy methodImaging modalitiesDesmoplastic natureGenetic alterationsTissue collectionNeedle choicePrecision medicineCholangiocarcinoma
2011
Histological Diagnosis
Jain D, West A. Histological Diagnosis. 2011, 103-123. DOI: 10.1007/978-1-4419-8327-5_8.Peer-Reviewed Original ResearchVenous systemBlood flowHepatic blood flowPortal venous systemCareful clinicopathological correlationHepatic arterial systemReduced blood flowCommon risk factorsIschemic injury resultsVariety of congenitalHepatic venous systemHypercoagulable stateChronic ischemiaHepatocyte necrosisHistological diagnosisClinicopathological correlationBiliary treePathologic diagnosisRisk factorsVascular disordersBiliary disordersHepatic parenchymaInjury resultsCorrect diagnosisHepatic sinusoids